FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/10/021481 [Registered on: 01/10/2019] Trial Registered Prospectively
Last Modified On: 22/11/2019
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   To compare Drug Utilization and effects between Ayurveda and Allopathy treatment in patients with Bronchial Asthma. 
Scientific Title of Study   Comparative study of Drug Utilization and effects in Ayurveda and Conventional treatment in Bronchial Asthma. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  ANANYA A NAYAK 
Designation  STUDENT 
Affiliation  MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES 
Address  DEPARTMENT OF PHARMACY PRACTICE, MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES, MANIPAL ACADEMY OF HIGHER EDUCATION, MANIPAL

Udupi
KARNATAKA
576104
India 
Phone  7975827672  
Fax    
Email  an17.ananya@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR KANAV KHERA 
Designation  ASSISTANT PROFESSOR, SENIOR SCALE 
Affiliation  MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES 
Address  DEPARTMENT OF PHARMACY PRACTICE, MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES, MANIPAL ACADEMY OF HIGHER EDUCATION, MANIPAL

Udupi
KARNATAKA
576104
India 
Phone  7889271828  
Fax    
Email  kanav.khera@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  ANANYA A NAYAK 
Designation  STUDENT 
Affiliation  MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES 
Address  DEPARTMENT OF PHARMACY PRACTICE, MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES, MANIPAL ACADEMY OF HIGHER EDUCATION, MANIPAL


KARNATAKA
576104
India 
Phone  7975827672  
Fax    
Email  an17.ananya@gmail.com  
 
Source of Monetary or Material Support  
DEPARTMENT OF PHARMACY PRACTICE, MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES, MADHAV NAGAR, MANIPAL, KARNATAKA 576104  
DIVISION OF AYURVEDA, CIMR, MANIPAL ACADEMY OF HIGHER EDUCATION, MANIPAL, KARNATAKA 576104 
KASTURBA HOSPITAL, UDUPI-HEBRI ROAD, MADHAV NAGAR, MANIPAL, KARNATAKA 576104  
 
Primary Sponsor  
Name  NA 
Address  NA 
Type of Sponsor  Other [NA] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
ANANYA A NAYAK  KASTURBA HOSPITAL, MANIPAL  DEPARTMENT OF RESPIRATORY MEDICINE, 1ST FLOOR, NEW OPD BLOCK, KASTURBA HOSPITAL, UDUPI-HEBRI ROAD, MADHAV NAGAR, MANIPAL, KARNATAKA 576104
Udupi
KARNATAKA 
7975827672

an17.ananya@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
KASTURBA MEDICAL COLLEGE AND KASTURBA HOSPITAL INSTITUTIONAL ETHICS COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J454||Moderate persistent asthma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  Out patients visiting the Respiratory and Ayurveda departments. 
 
ExclusionCriteria 
Details  1. Patients with cardiovascular disease (Cardiac arrest, Arrhythmia, Congenital Heart Disease, Stroke).
2. Patients with hepatic and renal impairment.
3. Pregnant and lactating women.
4. Patients with neurological impairment. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Drug utilization patterns and effects of treatment in patients with Bronchial Asthma will be assessed.  Data will be collected for 12 months which will be followed by organizing and analysis of the data collected for 2 months and then 1 month will be used to prepare a report.  
 
Secondary Outcome  
Outcome  TimePoints 
Quality of life of patients will be assessed along with the direct cost of therapy per patient.  Data will be collected for 12 months which will be followed by organizing and analysis of the data collected for 2 months and then 1 month will be used to prepare a report. 
 
Target Sample Size   Total Sample Size="250"
Sample Size from India="250" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   07/10/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="24" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

This is a prospective observational study which compares the Drug Utilization patterns and effects in Ayurveda and Conventional treatment in patients with Bronchial Asthma which will be conducted in India in Kasturba Hospital, Manipal in a minimum of 250 patients for the approved duration of study. The primary objective of this study is to study the Drug Utilization patterns and effects of therapy in Ayurveda and Conventional treatment in patients with Bronchial Asthma and the secondary objective of this study is to study the Quality of Life among Bronchial Asthma patients along with assessment of direct cost of therapy per patient. The drug utilization patterns will be compared among patients of out-patient department in Ayurveda and Respiratory medicine separately. The information obtained will be noted in a suitable designed CRF. Follow-up will be done on the visit or by contacting the patient. The Quality of life will be measured using Asthma Quality of Life Questionnaire (AQLQ), a standardized widely available and validated instrument to assess quality of life in Asthmatic patients. Efficacy will be assessed according to the domains in the Quality of Life Questionnaire. As a routine investigation, the direct cost burden will be compared between both the therapies and will also be calculated for every patient. The confidentiality of the patient data collected will be duly respected and the name of the patient will not be noted under any circumstance.

 
Close